---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000898"
form_type: "8-K"
ticker: "VANI"
cik: "0001266806"
company_name: "Vivani Medical, Inc."
filed_at: "2025-05-29T23:59:59+00:00"
generated_at: "2026-05-20T05:29:22.378328+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vivani Medical files Form 10 for spin-off of Cortigent; expects Nasdaq listing in Q3 2025

## Summary
- Cortigent files Form 10 to spin off from Vivani as independent Nasdaq company; completion expected Q3 2025.
- Orion Visual Cortical Prosthesis completed Early Feasibility Study in March 2025; has FDA Breakthrough Device designation.
- Cortigent advancing Stroke Recovery System to improve arm/hand movement recovery after stroke paralysis.
- Vivani will focus solely on NanoPortal GLP-1 implants for chronic weight management and type 2 diabetes.
- Spin-off requires final board approval, tax opinion, and SEC/Nasdaq clearance; shares distributed to Vivani stockholders.

## SEC filing metadata
- accession: 0001753926-25-000898
- form_type: 8-K
- ticker: VANI
- cik: 0001266806
- company_name: Vivani Medical, Inc.
- filed_at: 2025-05-29T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1266806/000175392625000898/0001753926-25-000898-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1266806/000175392625000898/vani-20250529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000898
- JSON: https://secwatch.observer/filing/0001753926-25-000898.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000898.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.